Related Experiment Video
Updated: Feb 26, 2026

Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter
Published on: March 31, 2022
dMMR killer: A conditional suicide gene that preferentially kills DNA mismatch repair-deficient cells
Shinta Saito1, Shingo Kato2,3, Usaki Arai1
1Department of Life and Environmental System Science, Graduate School of Nanobioscience, Yokohama City University, Yokohama 236-0027, Japan.
Abstract:
DNA mismatch repair (MMR) plays a crucial role in maintaining the integrity of the human genome, and impairments in this DNA repair mechanism are responsible for more than 10% of all malignant tumors. Thus, developing a strategy for stage-independent killing of MMR-deficient cells is of great significance in cancer therapy. Here, we show that transient transfection of artificial DNA constructs results in efficient killing of MMR-deficient cancer cells. These constructs were designed so that an intact suicide gene is formed and expressed in the cells, depending on a functional defect in MMR that inhibits single-strand annealing-mediated DNA recombination. In vivo anticancer activity was confirmed in HCT116 xenograft tumor models. Our findings suggest that a cellular DNA recombination-dependent suicide gene can provide a novel tool to selectively kill MMR-deficient tumors, including those resistant to immunotherapy.
Insights
Researchers developed a novel gene therapy to kill cancer cells lacking DNA mismatch repair (MMR). This approach uses artificial DNA constructs to selectively target and eliminate MMR-deficient tumors, offering a new avenue for cancer treatment.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- DNA mismatch repair (MMR) is vital for genome integrity.
- MMR deficiency is implicated in over 10% of human cancers.
- Targeting MMR-deficient cells is a significant therapeutic goal.
Purpose of the Study:
- To develop a strategy for stage-independent killing of MMR-deficient cancer cells.
- To create a novel suicide gene therapy exploiting MMR defects.
Main Methods:
- Transient transfection of artificial DNA constructs into cancer cells.
- Design of constructs to form an active suicide gene dependent on MMR deficiency.
- Evaluation of in vitro and in vivo anticancer activity in HCT116 xenograft models.
Main Results:
- Artificial DNA constructs efficiently killed MMR-deficient cancer cells.
- The suicide gene's activation relies on MMR-mediated inhibition of DNA recombination.
- Demonstrated in vivo anticancer activity in a tumor xenograft model.
Conclusions:
- A novel DNA recombination-dependent suicide gene effectively targets MMR-deficient tumors.
- This approach offers a potential new therapeutic tool for MMR-deficient cancers.
- The strategy may overcome resistance to immunotherapy in certain cancers.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Other Unique Bacteria
Abnormal Proliferation
Fixing Double-strand Breaks
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

